Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Dogecoin Perfect Bottom Signal? Price Tests 5-Year Support Level

Dogecoin Perfect Bottom Signal? Price Tests 5-Year Support Level

CryptoNewsNetCryptoNewsNet2026/06/15 13:18
By:CryptoNewsNet
Back to the list

Dogecoin Perfect Bottom Signal? Price Tests 5-Year Support Level

Dogecoin Perfect Bottom Signal? Price Tests 5-Year Support Level image 0  thecryptobasic.com 25 m
Dogecoin Perfect Bottom Signal? Price Tests 5-Year Support Level image 1

Dogecoin has fallen back to one of the most important technical levels on its long-term chart, with price now sitting directly on a multi-year support.

According to an analysis from Cryptollica, this support trendline has guided the asset’s market structure since 2021. Recent downward price action has now seen Dogecoin ($DOGE) once again testing this zone, which aligns with the lower boundary of a multi-year ascending channel.

While sentiment around the meme coin and the broader crypto market remains cautious, the Sunday analysis suggests the current zone could mark a turning point for $DOGE, potentially setting it up for the next phase of the market cycle.

Dogecoin at Five-Year Support

An accompanying chart highlights a rising “bottom line” that has remained intact for more than five years. Since the explosive rally in early February 2021 that pushed Dogecoin from $0.037 to a high of $0.088, every major correction has eventually found support near this trendline.

Dogecoin Perfect Bottom Signal? Price Tests 5-Year Support Level image 2 Dogecoin at 5-Year Support/Cryptollica

For context, in June 2022, $DOGE declined to a low of $0.049 before recovering. This aligned perfectly with the channel’s lower support line. A similar retest occurred in August 2023 when the token’s price briefly touched the area around $0.057. Both instances marked important turning points that preceded renewed upward momentum.

The last retest that brought $DOGE close to this key support was during the February market crash. Joining a broader market trend, the meme coin dropped to $0.080 but found support around the rising trendline.

Now, the current wave of downward price action has brought Dogecoin back toward the same structural support, with its price hovering near $0.088.

Cryptollica’s analysis suggests that the repeated reactions at this level strengthen its importance from a technical perspective. $DOGE has continued to respect this trendline despite several years of market volatility, with each revisit attracting enough demand to prevent a deeper correction.

As such, the commentator suggests that a “Dogecoin perfect bottom” might be forming as in previous cases, potentially targeting a price reversal to higher resistance levels.

Major Resistance Levels to Watch Should $DOGE Rebound

Although support has held historically, Dogecoin has also faced significant resistance above. Should it find support at the current “bottom line,” $DOGE needs to reclaim key resistance levels before any significant recovery can take shape.

Meanwhile, the chart identifies some of them, including the resistance line at $0.15. The token peaked around this level in January before continuing its sideways trend in the following months.

After this is a mid-channel resistance zone that repeatedly rejected higher prices in 2025. Several failed breakout attempts occurred near the $0.26 to $0.30 region between February and September 2025, with $DOGE eventually losing upward momentum. Before any sustained recovery can develop, the token would likely need to reclaim the channel midpoint and establish support above it.

Ultimately, a sustained rebound could push Dogecoin to the upper boundary of the ascending channel. The last time it visited this zone was in 2021 when it peaked at $0.74. According to the chart, reclaiming this trendline will see the leading meme coin finally surpass the $1 mark to around $1.50. This would mark a new all-time high for $DOGE and represent a 1,604% growth from the current market price.

In the meantime, market activity seems to be picking up again, with trading volume increasing 31% in the last 24 hours to $663 million. Open interest has also increased slightly during the same period to $1.16 billion, signaling returning derivative interest.

Dogecoin Perfect Bottom Signal? Price Tests 5-Year Support Level image 3 Dogecoin Derivative Data | Coinglass
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"

Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.

华尔街见闻•2026/09/29 01:01

Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business

Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.

华尔街见闻•2026/09/29 00:51

AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose

This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.

华尔街见闻•2026/09/29 00:26